The increasing incidence of infectious diseases, the increasing number of accidents and trauma cases, the emergence of liquid biopsy tests, and a demand for blood donations and blood components are the major factors driving the growth of this market. The COVID-19 outbreak is a once-in-a-lifetime global public health crisis that is expected to have a significant impact on the blood collection tube market. In general, both hospital and independent laboratories review each test to determine whether to recommend consultations with laboratory haematologists for tests with a higher risk profile or to not offer tests that could not be performed safely. This had a negative impact on the market during the first few months of the pandemic, reducing the use of blood collection devices. However, rising caution and testing volumes, as well as the need for regular health and body checkups, will ensure market growth in the future.
Growing geriatric population, emergence of liquid biopsy tests, and increased blood donation campaigns are major factors driving the growth of the blood collection tubes market. Furthermore, the rising prevalence of chronic diseases as a result of changing lifestyles, as well as an increase in the number of people suffering from obesity, diabetes, and cardiovascular disease (CVD), which account for the majority of deaths, have been propelling market growth. Furthermore, an increase in the number of accidents and blood transfusions during surgeries propels the market forward. However, the risk of contracting infections as a result of unsanitary blood transfusion may limit the growth of the Blood Collection Tubes Market to some extent. Improved healthcare infrastructure around the world, as well as increased access to healthcare facilities in developing and underdeveloped countries, would, on the other hand, provide ample growth opportunities for market players in the coming years.
Also Check Source Link@ https://www.openpr.com/news/2493049/blood-collection-tubes-market-ongoing-investments-suggesting
Read More@ https://bit.ly/3m23Olf
